BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 964 filers reported holding BAXTER INTL INC in Q2 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $377,853 | -43.0% | 10,012 | -31.2% | 0.02% | -42.3% |
| Q2 2023 | $662,534 | +12.3% | 14,542 | 0.0% | 0.03% | +8.3% |
| Q1 2023 | $589,824 | +154.1% | 14,542 | +219.3% | 0.02% | +166.7% |
| Q4 2022 | $232,168 | +9.0% | 4,555 | +15.2% | 0.01% | 0.0% |
| Q3 2022 | $213,000 | -16.1% | 3,955 | 0.0% | 0.01% | -18.2% |
| Q2 2022 | $254,000 | -17.3% | 3,955 | 0.0% | 0.01% | -15.4% |
| Q1 2022 | $307,000 | -10.2% | 3,955 | -0.8% | 0.01% | -13.3% |
| Q4 2021 | $342,000 | +6.9% | 3,985 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $320,000 | +0.6% | 3,985 | +0.8% | 0.02% | 0.0% |
| Q2 2021 | $318,000 | -4.8% | 3,955 | 0.0% | 0.02% | -6.2% |
| Q1 2021 | $334,000 | +5.4% | 3,955 | 0.0% | 0.02% | -5.9% |
| Q4 2020 | $317,000 | -0.3% | 3,955 | 0.0% | 0.02% | -15.0% |
| Q3 2020 | $318,000 | -6.5% | 3,955 | 0.0% | 0.02% | 0.0% |
| Q2 2020 | $340,000 | -10.5% | 3,955 | -15.5% | 0.02% | -31.0% |
| Q1 2020 | $380,000 | -2.8% | 4,681 | 0.0% | 0.03% | +45.0% |
| Q4 2019 | $391,000 | -4.4% | 4,681 | 0.0% | 0.02% | -4.8% |
| Q3 2019 | $409,000 | +6.5% | 4,681 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $384,000 | +0.8% | 4,681 | 0.0% | 0.02% | 0.0% |
| Q1 2019 | $381,000 | +23.7% | 4,681 | 0.0% | 0.02% | +23.5% |
| Q4 2018 | $308,000 | -14.7% | 4,681 | 0.0% | 0.02% | 0.0% |
| Q3 2018 | $361,000 | +4.3% | 4,681 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $346,000 | +13.4% | 4,681 | 0.0% | 0.02% | +6.2% |
| Q1 2018 | $305,000 | +0.7% | 4,681 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $303,000 | +3.1% | 4,681 | 0.0% | 0.02% | -11.1% |
| Q3 2017 | $294,000 | +3.5% | 4,681 | 0.0% | 0.02% | -5.3% |
| Q2 2017 | $284,000 | +16.9% | 4,681 | 0.0% | 0.02% | +26.7% |
| Q1 2017 | $243,000 | +16.8% | 4,681 | 0.0% | 0.02% | +15.4% |
| Q4 2016 | $208,000 | -6.3% | 4,681 | 0.0% | 0.01% | -18.8% |
| Q3 2016 | $222,000 | -8.6% | 4,681 | -12.9% | 0.02% | 0.0% |
| Q2 2016 | $243,000 | -11.3% | 5,374 | -19.4% | 0.02% | -5.9% |
| Q1 2016 | $274,000 | +7.9% | 6,668 | 0.0% | 0.02% | +13.3% |
| Q4 2015 | $254,000 | +23.3% | 6,668 | +6.4% | 0.02% | +25.0% |
| Q3 2015 | $206,000 | -43.6% | 6,268 | +20.1% | 0.01% | -42.9% |
| Q2 2015 | $365,000 | +2.0% | 5,218 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $358,000 | +2.6% | 5,218 | +9.6% | 0.02% | 0.0% |
| Q4 2014 | $349,000 | +2.3% | 4,762 | 0.0% | 0.02% | +5.0% |
| Q3 2014 | $341,000 | -2.8% | 4,762 | -2.1% | 0.02% | -9.1% |
| Q2 2014 | $351,000 | -3.8% | 4,862 | -2.0% | 0.02% | +4.8% |
| Q1 2014 | $365,000 | +5.8% | 4,962 | 0.0% | 0.02% | +5.0% |
| Q4 2013 | $345,000 | +23.7% | 4,962 | +16.8% | 0.02% | +11.1% |
| Q3 2013 | $279,000 | +32.9% | 4,250 | +39.9% | 0.02% | +28.6% |
| Q2 2013 | $210,000 | – | 3,037 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |